Tudor Investment Corp’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-85,609
Closed -$2.54M 2912
2023
Q4
$2.54M Buy
+85,609
New +$1.7M 0.02% 984
2022
Q4
Sell
-87,428
Closed -$418K 2961
2022
Q3
$418K Sell
87,428
-232,719
-73% -$1.23M 0.01% 1527
2022
Q2
$1.44M Sell
320,147
-254,522
-44% -$1.11M 0.04% 675
2022
Q1
$2.73M Buy
574,669
+32,361
+6% +$179K 0.06% 408
2021
Q4
$4.02M Buy
542,308
+58,318
+12% +$362K 0.07% 342
2021
Q3
$2.74M Buy
483,990
+99,197
+26% +$573K 0.04% 532
2021
Q2
$2.54M Buy
384,793
+310,721
+419% +$2.17M 0.05% 464
2021
Q1
$600K Buy
+74,072
New +$605K 0.01% 1067
2020
Q4
Sell
-277,460
Closed -$999K 1700
2020
Q3
$999K Buy
277,460
+212,923
+330% +$860K 0.04% 566
2020
Q2
$297K Buy
+64,537
New +$274K 0.01% 889
2018
Q1
Sell
-18,321
Closed -$117K 1307
2017
Q4
$117K Buy
+18,321
New +$113K ﹤0.01% 1019
2017
Q2
Sell
-24,493
Closed -$95K 1443
2017
Q1
$95K Sell
24,493
-8,387
-26% -$24.5K ﹤0.01% 1311
2016
Q4
$67K Buy
32,880
+2,631
+9% +$5.28K ﹤0.01% 1328
2016
Q3
$81K Sell
30,249
-33,051
-52% -$96.1K ﹤0.01% 1352
2016
Q2
$195K Buy
+63,300
New +$397K ﹤0.01% 1415

Other funds holding IMGN

Tudor Investment Corp's IMGN Position: Q1 2024 in Review

Tudor Investment Corp sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 85,609 shares — an estimated $2.54M sold.

Tudor Investment Corp first reported a position in IMGN in Q2 2016 and held it in 15 quarters. The position peaked at $4.02M in Q4 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Tudor Investment Corp reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 85,609 Immunogen Inc shares in Q1 2024, an estimated $2.54M.
  • Tudor Investment Corp first reported a position in Immunogen Inc in Q2 2016 and held it in 15 quarters.
  • Tudor Investment Corp's Immunogen Inc position peaked at $4.02M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.